Please login to the form below

Not currently logged in
Email:
Password:

Aimovig

This page shows the latest Aimovig news and features for those working in and with pharma, biotech and healthcare.

Novartis and Amgen come to blows over migraine partnership

Novartis and Amgen come to blows over migraine partnership

Aimovig was approved by the FDA last year as a once-monthly, self-injected preventive treatment for migraines, and was the first CGRP inhibitor to reach the market. ... That profile means that it differs from Aimovig and will not “fully compete” with

Latest news

More from news
Approximately 6 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics